Search

JANE DURGA, Nestlé Research Centre, Lausanne REFERENCE: Lancet 2007; 369:208 A trial that randomised older adults to receive a folic acid supplement or placebo has shown that folic acid can significa

Francis Giles Ken Kaushansky Heather Leitch Nancy Berliner Corrado Tarella Vincent Rajkumar Robert Kyle Aurora Kinase BCR-ABL Inhibitor Beats T315-I Mutation in Patients with Chronic Myeloid Leukemia

PAT DOYLE, London School of Hygiene and Tropical Medicine REFERENCE: BJOG 2007 114:170 Underweight women were found to be at increased risk of miscarriage in a study published in the British Journal o

RODGER MACARTHUR, Wayne State University, Detroit REFERENCE: Lancet 2006; 368: 2125-35 A three-class HIV antiretroviral therapy is not necessary, according to data published in the Lancet. The FIRST s

NILESH SAMANI, Glenfield Hospital, Leicester REFERENCE: Lancet 2007; 369:107 A new genetic test could help predict which individuals will develop coronary heart disease among those with similar conven

CHARLOTTE WATTS, London School of Hygiene and Tropical Medicine REFERENCE: Lancet 2006; 368: 1973-83 A large and groundbreaking study has shown that microfinance, combined with a gender and HIV traini

IAN SMITH, Royal Marsden Hospital, London REFERENCE: Lancet 369:29 Confirmation of the life-extending benefits of trastuzumab adjuvant therapy for early breast cancer has been published recently in th

RICHARD LEVINE, National Institutes of Health, Bethesda REFERENCE: N Engl J Med 2006; 355:992 In pregnant women circulating levels of the anti-angiogenic substances: soluble endoglin and soluble Flt-1

Dennis Slamon George Peoples James Holland Massimo Christofanilli Trastuzumab: Mature Results in Early Breast Cancer Show Superiority REFERENCE: San Antonio Breast Cancer Symposium 2006, Abstract: 52

Martin Müller Charles Linker Andreas Hochhaus Christian Buske Katarina Le Blanc Stephen Emerson Alessandro Vannucchi Kanti Rai Richard Schlenk BCR-ABL Mutations After Imatinib Failure: Impact on Respo

CHRIS PLOWE, University of Maryland School of Medicine, Baltimore REFERENCE: N Engl J Med 2006; 355:1955-66 In Malawi chloroquine was taken out of use in 1993 because its failure rate was so high. How

PAUL WEIDLE, Centers for Disease Control and Prevention, Atlanta REFERENCE: Lancet 2006; 368:1587-94 In rural sub-Saharan Africa there are many barriers to taking antiretroviral therapy successfully.